Similar to that on circulating free DNA or cell-free DNA and several oncoproteins, such as prostate-specific antigen (PSA) and alpha-fetoprotein (AFP), emerging evidence has suggested that EV-associated ncRNAs and proteins can serve as biomarkers and diagnostic, prognostic, and therapeutic targets in cancer patients. The gene discussed is AFP; the disease is cancer.